Stock Events

Stock Events

Nabriva Therapeutics (NBRVF) Q2 2022 Earnings

3AugExpected

Q3 2021

Q4 2021

Q1 2022

Q2 2022

-5

-3.4

-1.79

-0.19

Details

Expected EPS

-5

Actual EPS

-4.5

Surprise EPS

0.5

Surprise Percent

+10%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -4.5 per share for Q2 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.